Dr. Reddy’s Laboratories enters into confidential settlement agreement with Celgene

02 Apr 2019 Evaluate

Dr. Reddy’s Laboratories has entered into a confidential settlement agreement with Celgene for its Abbreviated New Drug Submissions (ANDS) related to a generic version of Revlimid brand capsules, (Lenalidomide) pending before Health Canada.

Pursuant to this confidential settlement, the parties agreed to discontinue all legal proceedings involving certain of Celgene’s Canadian patents related to Lenalidomide and the company’s ANDS for generic versions of Celgene's Lenalidomide capsules pending before Health Canada. Other terms of the agreement are confidential.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×